Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
AVEO PHARMACEUTICALS, INC. (AVEO)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 15.1% | 15.2% | 15.9% | 17.6% | 10.6% | 6.9% | 1.9% | 0.0% |
| Gross profit | 84.9% | 84.8% | 84.1% | 82.4% | 89.4% | 93.1% | 98.1% | 100.0% |
| Selling, general and administrative | 71.7% | 82.5% | 102.9% | | 212.1% | 321.1% | 470.2% | |
| Research and development | 42.1% | 45.7% | 50.0% | 62.2% | 96.9% | 165.5% | 288.6% | 376.8% |
| General and administrative | | | | 37.0% | | | | 149.7% |
| Depreciation | 0.1% | 0.1% | 0.1% | 0.2% | 0.2% | 0.4% | 0.5% | 0.3% |
| EBIT | -26.0% | -39.9% | -64.4% | -117.2% | -238.8% | -428.5% | -729.2% | -727.3% |
| Pre-tax income | -30.8% | -45.7% | -67.6% | -126.1% | -225.5% | -398.3% | -689.4% | -591.2% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -30.8% | -45.7% | -67.6% | -126.1% | -225.5% | -398.3% | -689.4% | -591.2% |
|